DTcP-Hib

N/A

Report date: 2025/03/19 08:55:24

Base Information

Drug NameDTcP-Hib
Drug Alias Namecombined vaccine (Tianjin CanSino Biotechnology)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMeningitisPoliomyelitisTetanus +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCanSino Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCanSino Biologics Inc
Inactive CompaniesN/A
Active IndicationsMeningitisPoliomyelitisTetanus +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A